Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy

Authors

Phillip L. Pearl, George Washington UniversityFollow
Robert J. McCarter, George Washington University
Colleen L. McGavin, George Washington University
Yuezhou Yu, Children's National Medical Center
Fabian Sandoval, MedStar Research Institute, Washington, DC
Stacey Trzcinski, Children's National Medical Center
Shireen M. Atabaki, George Washington UniversityFollow
Tammy Tsuchida, George Washington UniversityFollow
John N. van den Anker, George Washington UniversityFollow
Jianping He, Children's National Medical Center
Pavel Klein, Mid-Atlantic Epilepsy and Sleep Center Bethesda, MarylandFollow

Document Type

Journal Article

Publication Date

2013

Journal

Epilepsia

Volume

Volume 54, Issue 9

Inclusive Pages

e135-e137

Keywords

Anticonvulsants--therapeutic use; Brain Injuries--complications; Craniocerebral Trauma--complications; Epilepsy, Post-Traumatic--drug therapy; Piracetam--analogs & derivatives

Comments

PMCID: PMC3769484 [Available on 2014/9/1]

APA Citation

Pearl, P. L., Mccarter, R., Mcgavin, C. L., Yu, Y., Sandoval, F., Trzcinski, S., Atabaki, S.M., Tsuchida, T., van den Anker, J.N., He, J., Klein, P. (2013). Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy. Epilepsia, 54(9), e135-e137.

Peer Reviewed

1